234 related articles for article (PubMed ID: 14960525)
1. Steatosis affects chronic hepatitis C progression in a genotype specific way.
Rubbia-Brandt L; Fabris P; Paganin S; Leandro G; Male PJ; Giostra E; Carlotto A; Bozzola L; Smedile A; Negro F
Gut; 2004 Mar; 53(3):406-12. PubMed ID: 14960525
[TBL] [Abstract][Full Text] [Related]
2. Effect of antiviral treatment on evolution of liver steatosis in patients with chronic hepatitis C: indirect evidence of a role of hepatitis C virus genotype 3 in steatosis.
Castéra L; Hézode C; Roudot-Thoraval F; Lonjon I; Zafrani ES; Pawlotsky JM; Dhumeaux D
Gut; 2004 Mar; 53(3):420-4. PubMed ID: 14960527
[TBL] [Abstract][Full Text] [Related]
3. Glucose intolerance and hypoadiponectinemia are already present in lean patients with chronic hepatitis C infected with genotype non-3 viruses.
Anty R; Gelsi E; Giudicelli J; Mariné-Barjoan E; Gual P; Benzaken S; Saint-Paul MC; Sadoul JL; Huet PM; Tran A
Eur J Gastroenterol Hepatol; 2007 Aug; 19(8):671-7. PubMed ID: 17625437
[TBL] [Abstract][Full Text] [Related]
4. Correlation of serum adiponectin levels and hepatic steatosis in hepatitis C virus genotype 1 infection.
Kara B; Gunesacar R; Doran F; Kara IO; Akkiz H
Adv Ther; 2007; 24(5):972-82. PubMed ID: 18029322
[TBL] [Abstract][Full Text] [Related]
5. Impact of liver steatosis on the antiviral response in the hepatitis C virus-associated chronic hepatitis.
Soresi M; Tripi S; Franco V; Giannitrapani L; Alessandri A; Rappa F; Vuturo O; Montalto G
Liver Int; 2006 Nov; 26(9):1119-25. PubMed ID: 17032413
[TBL] [Abstract][Full Text] [Related]
6. Hepatic steatosis in hepatitis C virus genotype 3 infection: does it correlate with body mass index, fibrosis, and HCV risk factors?
Sharma P; Balan V; Hernandez J; Rosati M; Williams J; Rodriguez-Luna H; Schwartz J; Harrison E; Anderson M; Byrne T; Vargas HE; Douglas DD; Rakela J
Dig Dis Sci; 2004 Jan; 49(1):25-9. PubMed ID: 14992430
[TBL] [Abstract][Full Text] [Related]
7. Liver steatosis in chronic hepatitis C: a morphological sign suggesting infection with HCV genotype 3.
Rubbia-Brandt L; Leandro G; Spahr L; Giostra E; Quadri R; Malé PJ; Negro F
Histopathology; 2001 Aug; 39(2):119-24. PubMed ID: 11493327
[TBL] [Abstract][Full Text] [Related]
8. Insulin resistance: a major factor associated with significant liver fibrosis in Egyptian patients with genotype 4 chronic hepatitis C.
El Ray A; Asselah T; Moucari R; El Ghannam M; Taha AA; Saber MA; Akl M; Atta R; Shemis M; Radwan AS; Ghali A; Paradis V; Marcellin P
Eur J Gastroenterol Hepatol; 2013 Apr; 25(4):421-7. PubMed ID: 23470266
[TBL] [Abstract][Full Text] [Related]
9. Insulin resistance is a cause of steatosis and fibrosis progression in chronic hepatitis C.
Fartoux L; Poujol-Robert A; Guéchot J; Wendum D; Poupon R; Serfaty L
Gut; 2005 Jul; 54(7):1003-8. PubMed ID: 15951550
[TBL] [Abstract][Full Text] [Related]
10. Steatosis in chronic hepatitis C: relationship to the virus and host risk factors.
Matos CA; Perez RM; Pacheco MS; Figueiredo-Mendes CG; Lopes-Neto E; Oliveira EB; Lanzoni VP; Silva AE; Ferraz ML
J Gastroenterol Hepatol; 2006 Aug; 21(8):1236-9. PubMed ID: 16872303
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis C virus-associated hypobetalipoproteinemia is correlated with plasma viral load, steatosis, and liver fibrosis.
Petit JM; Benichou M; Duvillard L; Jooste V; Bour JB; Minello A; Verges B; Brun JM; Gambert P; Hillon P
Am J Gastroenterol; 2003 May; 98(5):1150-4. PubMed ID: 12809841
[TBL] [Abstract][Full Text] [Related]
12. The impact of steatosis on disease progression and early and sustained treatment response in chronic hepatitis C patients.
Patton HM; Patel K; Behling C; Bylund D; Blatt LM; Vallée M; Heaton S; Conrad A; Pockros PJ; McHutchison JG
J Hepatol; 2004 Mar; 40(3):484-90. PubMed ID: 15123364
[TBL] [Abstract][Full Text] [Related]
13. Alcohol is an important co-factor for both steatosis and fibrosis in Northern Italian patients with chronic hepatitis C.
Fabris P; Floreani A; Carlotto A; Giordani MT; Baldo V; Stecca C; Marchioro L; Tramarin A; Bertin T; Negro F; de Lalla F
J Hepatol; 2004 Oct; 41(4):644-51. PubMed ID: 15464246
[TBL] [Abstract][Full Text] [Related]
14. Influence of steatosis on progression of fibrosis and virological response in chronic hepatitis C cases.
Rafi H; Kabbaj N; Salihoun M; Amrani L; Acharki M; Guedira M; Nya M; Amrani N
Arab J Gastroenterol; 2011 Sep; 12(3):136-8. PubMed ID: 22055591
[TBL] [Abstract][Full Text] [Related]
15. Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity.
Adinolfi LE; Gambardella M; Andreana A; Tripodi MF; Utili R; Ruggiero G
Hepatology; 2001 Jun; 33(6):1358-64. PubMed ID: 11391523
[TBL] [Abstract][Full Text] [Related]
16. Clinical implications of hepatic steatosis in patients with chronic hepatitis C: a multicenter study of U.S. veterans.
Hu KQ; Currie SL; Shen H; Cheung RC; Ho SB; Bini EJ; McCracken JD; Morgan T; Bräu N; Schmidt WN; Jeffers L; Wright TL;
Dig Dis Sci; 2007 Feb; 52(2):570-8. PubMed ID: 17226072
[TBL] [Abstract][Full Text] [Related]
17. Factors associated with liver steatosis and fibrosis in chronic hepatitis C patients.
Cholet F; Nousbaum JB; Richecoeur M; Oger E; Cauvin JM; Lagarde N; Robaszkiewicz M; Gouérou H
Gastroenterol Clin Biol; 2004 Mar; 28(3):272-8. PubMed ID: 15094677
[TBL] [Abstract][Full Text] [Related]
18. Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3.
Rubbia-Brandt L; Quadri R; Abid K; Giostra E; Malé PJ; Mentha G; Spahr L; Zarski JP; Borisch B; Hadengue A; Negro F
J Hepatol; 2000 Jul; 33(1):106-15. PubMed ID: 10905593
[TBL] [Abstract][Full Text] [Related]
19. [Steatosis and non-alcoholic steatohepatitis in patients with chronic hepatitis due to hepatitis C virus infection].
Coral G; de Mattos AA; de Mattos AZ; dos Santos DE
Arq Gastroenterol; 2006; 43(4):265-8. PubMed ID: 17406752
[TBL] [Abstract][Full Text] [Related]
20. Association of the prevalence and grade of steatosis in patients with chronic hepatitis C with the host and viral factors.
Liakina V; Speiciené D; Irnius A; Semuchiniené T; Valantinas J
Acta Gastroenterol Belg; 2007; 70(3):260-6. PubMed ID: 18074734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
